Goldman Sachs Resumes Ideaya Biosciences (IDYA) at Neutral
Tweet Send to a Friend
(Updated - July 10, 2025 6:29 AM EDT)
Goldman Sachs analyst Corinne Jenkins resumes coverage on Ideaya Biosciences (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Corinne Jenkins resumes coverage on Ideaya Biosciences (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
